ALGN
Align Technology, Inc.$182.16
Unclear
Target $187.93
Report: Mar 07, 2026Healthcare • Medical - Devices • Mature CompounderSnapshot
Decision-first overview with recommendation, valuation anchor, and current setup.
Company Overview
Research Snapshot
Price History
Pelican View
Current$182.16+3.2%
Rec: UnclearConviction: Medium
Entry Target
$144.56
(21% below current)
Fair Value
$187.93
(3% above current)
Stop Loss
$122.00
(33% below current)
Position Size
Starter
Time Horizon
Transitional
Key Metrics
Live Snapshot
Market Data
52 Week High$208.31
52 Week Low$122.00
Avg. 3 Month Volume1.23M
Efficiency
LTM Gross Margin67.2%
LTM EBITDA Margin21.4%
LTM EBIT Margin14.5%
LTM Operating Margin13.5%
LTM ROA6.6%
LTM ROE10.4%
LTM ROIC21.2%
LTM ROCE13.9%
Capital Structure
Market Cap (MM)$12.2B
Enterprise Value (MM)$11.2B
Shares Outstanding71.67M
Total Debt (MM)$82.51M
Cash & Equivalents (MM)$1.09B
LTM Net Debt (MM)$-1.01B
LTM Net Debt/EBITDA-1.2x
Growth
TTM Rev. Growth0.9%
Last 3-Yr Rev. CAGR2.6%
Last 3-Yr EBITDA CAGR4.5%
Last 3-Yr EPS CAGR7.0%
Valuation
Street Target Price$197.30
LTM EV/Revenue2.8x
LTM EV/Gross Profit4.1x
LTM EV/EBIT19.1x
LTM EV/EBITDA13.0x
LTM P/E29.8x
LTM EV/FCF22.8x
LTM P/FCF24.9x
LTM P/TB2.2x
LTM P/B3.0x
Dividend Yield0.0%
Payout Ratio0.0%
Executive SummarySituation: Current price is $182.16 versus fair value $187.93 (3.2% expected return), and valuation confidence is stable. Debate: Bull case depends on Direct Fabrication (3D Printing) Commercialization Align is piloting direct 3D printing of aligners, which is expected to be margin accretive by 2027. Bear case centers on Accelerated ASP Erosion The mechanism of impairment is a continued shift in product mix toward lower-priced 'non-comprehensive' packages and increased competition in China, which could drive consolidated ASP below the 1,200 USD level. Conclusion: Recommendation is Unclear; maintain no position until reliability and catalyst evidence improve.
Bull Case
1. Digital workflow switching costs remain high, protecting a 17.2 percentage point gross margin premium over peers. 2. DSO partnerships (25% of volume) provide a high-growth channel that bypasses traditional retail weakness. 3. Direct Fabrication (3D printing) technology will become margin accretive by 2027, offsetting current ASP pressure.
Bear Case
1. Permanent pricing erosion as the product mix shifts toward lower-margin 'non-comprehensive' cases. 2. Moat erosion from low-cost competitors and the implementation of Volume-Based Procurement (VBP) in China. 3. US retail demand remains structurally impaired by high interest rates and declining consumer discretionary spending.
Key Catalysts
Long-Term (18+ months)Impact: High
Direct Fabrication (3D Printing) Commercialization Align is piloting direct 3D printing of aligners, which is expected to be margin accretiv...
Mid-Term (6-18 months)Impact: Moderate
DSO Partnership Re-acceleration DSOs now represent 25% of total volume and are growing at double-digit rates. Continued penetration into lar...
Long-Term (18+ months)Impact: Moderate
Align is currently relevant for analysis because it has just completed a major restructuring and is trading near its 200-day moving average...
Primary Risks
Concern: High
Accelerated ASP Erosion The mechanism of impairment is a continued shift in product mix toward lower-priced 'non-comprehensive' packages and...
Concern: Medium
Moat Erosion via Patent Expiration The expiration of foundational Invisalign patents allows competitors to offer similar physical products a...
Concern: Medium
Stewardship is strong, characterized by a 'fortress' balance sheet and a commitment to per-share value. While insider ownership is low at 0....
Recent Activity
2026-02-05SEC Filing (8-K)
+8.88%Align Technology reported Q4 2025 record revenue of $1.048 billion, up 5.3% YoY, with Clear Aligner volume up 7.7% YoY.
2025-07-31SEC Filing (8-K)
-36.63%Align Technology reported Q2 2025 revenue of $1.012 billion, down 1.6% YoY, with Clear Aligner volume up 0.3% YoY.
2025-07-23Press Release
+5.19%Invisalign® Palatal Expander System By Align Technology Now Available In Malaysia For Skeletal And Dental Expansion In Growing Patients
2025-05-21SEC Filing (8-K)
-5.84%Align Technology holds 2025 Annual Meeting with key proposals approved
2025-04-09Market Movement
+14.35%Market/Sector Move +14.35%
Valuation Table
9.8/10Decision Grade